PLANTATION, FLA, Oct. 3, 2022
/PRNewswire/ - Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin")
today announced that, effective September
30, 2022, it completed its previously announced change of
jurisdiction of incorporation from the Province of Ontario, Canada to the State of Delaware, USA (the "Domestication").
In light of the completion of the Domestication, Akumin is now
subject to the General Corporation Law of the State of Delaware. The stock symbol of Akumin
on both the NASDAQ Stock Exchange and the Toronto Stock Exchange
will continue to be "AKU".
The Domestication was approved by a special resolution of
shareholders of Akumin passed at the annual general and special
meeting of shareholders held on June 30,
2022 and subsequently by the board of directors of
Complete details regarding the Domestication were outlined in
the management information circular of Akumin dated May 17, 2022, a copy of which is available at
Akumin's profile on EDGAR at www.sec.gov and on www.sedar.com.
Akumin is a national leader in comprehensive outpatient
radiology and oncology solutions and a partner of choice for U.S.
hospitals, health systems and physician groups. Akumin provides
fixed-site outpatient radiology and oncology services through a
network of 234 owned and/or operated centers; as well as outpatient
radiology and oncology solutions to approximately 1,000 hospitals
and health systems across 48 states. Akumin combines clinical and
operational expertise with the latest advances in technology and
information systems to deliver patient-centered innovation, service
standardization and exceptional healthcare value to its patients
and partners. For more information, visit www.akumin.com.
SOURCE Akumin Inc.